Nephrocare Health Services (NSE:NEPHROPLUS, BOM:544647) board approved collateral and security support of up to 1.40 billion Indian rupees for its overseas subsidiaries to help them obtain credit facilities from overseas banks, according to a filing.
The board approved support of up to 700 million rupees for Nephrocare Health Services International, Singapore, and Nephrocare Health Services Saudi Arabia each, the filing said.
Shares of the company fell nearly 6% in Wednesday's trade.